The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2014
Filed:
Sep. 23, 2009
Applicants:
Rajinder Singh, Belmont, CA (US);
Somasekhar Bhamidipati, Foster City, CA (US);
Vadim Markovtsov, San Mateo, CA (US);
Inventors:
Rajinder Singh, Belmont, CA (US);
Somasekhar Bhamidipati, Foster City, CA (US);
Vadim Markovtsov, San Mateo, CA (US);
Assignee:
Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/48 (2006.01); C07D 265/36 (2006.01); C07D 263/62 (2006.01); C07D 413/14 (2006.01); A61K 31/506 (2006.01); A61K 31/538 (2006.01); A61K 31/5383 (2006.01); A61K 31/423 (2006.01); A61P 35/00 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61K 31/538 (2013.01); A61K 31/423 (2013.01); C07D 265/36 (2013.01); A61K 31/506 (2013.01); C07D 263/62 (2013.01); A61K 31/5383 (2013.01); C07D 239/48 (2013.01); C07D 413/12 (2013.01);
Abstract
The present disclosure relates to 2,4-pyrimidinediamines substituted with tricyclic carbamates and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, such as JAK2 or JAK3, is therapeutically useful.